Bionime, a Taiwanese leading designer and manufacturer of blood glucose monitoring (BGM) devices, will participate a leading medical trade fair at Düsseldorf of MEDICA 2022. An integrated part of the trade fair, will from 14 to 17 November once more offer an overview of top trends in data-driven medicine.
Bionime was established in April 2003 with the goal of improving the lives of people with diabetes through better self-monitoring. Bionime is focused on designing and manufacturing accurate medical testing equipment of diabetes eco-system for 20 years. Bionime builds its own brand, Rightest, which aimed at improving the lives of people with well-lifestyle in diabetes patients, the CGM system provides 24-hour real-time glucose tracking and data transmission.
The Brand new “RIGHTEST iFree CGM” will be the first step stone for our mission! Based on industry 4.0 specifications, the RIGHTEST iFree CGM promises ease-to-use, as well as a mobile app available for any Bluetooth devices to record glucose and to communicate with relatives. Via the Internet cloud, hospital systems and doctor are allowing triage & continuous two-way interactions. “This, iFree CGM, we promise will let can affordable for whose needs the CGM targets”, says Roy Huang, CEO of Bionime.
Besides RIGHTEST iFree CGM, Bionime never stops improvements of traditional BGM. Max series take care of diabetes patients monitoring at home. With Bluetooth function, patients upload blood glucose records conveniently, which helps relatives and doctor knowing better. As for hospitalized patients, Rightest GM 700 Pro 2 is a point-of-care (POC) Blood Glucose monitoring system that personal BGM data can be integrated and transmitted via WIFI, Bluetooth, or Ethernet to Hospital Information System (HIS). With the help of the auto-coding function, Rightest GM 700 Pro 2 is able to eliminate the need for manual coding and delivery immediately accuracy. Also, a replaceable strip holder can avoid contamination caused by blood samples, bringing convenience to healthcare professionals due to its lightweight design and barcode scanner. Furthermore, Rightest GM 700 Pro 2 is certified and complies with the ISO 15197 guideline, CE marking, and TFDA international standard. GS 770 test strip reaching 10/10 accuracy standard measure by Rightest GM 700 Pro 2 compared with reference values from a YSI analyzer. As a result, all these ensure that Bionime can provide safe and accurate data in making the best treatment decision possible.
Bionime sincerely invites specialists and executives who are interesting in a new trend of medical management in the face of pandemic conditions to participate in 2022 MEDICAL FAIR at Düsseldorf and visit the booth #B65 HALL 1 from 14 to 17 November 2022.
Contact us by email: [email protected]
1 hall Booth: 65
Date: 14th Nov-17th Nov
Time: 10:00-18:00
Venue: Messe Düsseldorf, Düsseldorf, Germany
iFree, Free your life!
www.bionime.com